Cargando…
Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity
BACKGROUND: Cisplatin is a popular antineoplastic agent used to treat cervical cancer in women from low and middle-income countries. Cisplatin treatment is associated with ototoxicity, often resulting in hearing loss. In light of this, it is crucial to conduct baseline audiological assessments prior...
Autores principales: | Paken, Jessica, Govender, Cyril D., Pillay, Mershen, Ayele, Birhanu T., Sewram, Vikash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056627/ https://www.ncbi.nlm.nih.gov/pubmed/33879158 http://dx.doi.org/10.1186/s12905-021-01313-5 |
Ejemplares similares
-
Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa
por: Paken, Jessica, et al.
Publicado: (2021) -
Cisplatin-Associated Ototoxicity: A Review for the Health Professional
por: Paken, Jessica, et al.
Publicado: (2016) -
Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa
por: Paken, Jessica, et al.
Publicado: (2023) -
Perspectives and practices of ototoxicity monitoring
por: Paken, Jessica, et al.
Publicado: (2020) -
Cisplatin-associated ototoxicity: perspectives from a single institution cervical cancer cohort and implications for developing a locally responsive monitoring programme in a public healthcare setting
por: Paken, Jessica, et al.
Publicado: (2022)